全文获取类型
收费全文 | 27044篇 |
免费 | 2033篇 |
国内免费 | 739篇 |
专业分类
耳鼻咽喉 | 662篇 |
儿科学 | 524篇 |
妇产科学 | 703篇 |
基础医学 | 1825篇 |
口腔科学 | 524篇 |
临床医学 | 3122篇 |
内科学 | 8963篇 |
皮肤病学 | 31篇 |
神经病学 | 256篇 |
特种医学 | 1209篇 |
外国民族医学 | 2篇 |
外科学 | 5339篇 |
综合类 | 3401篇 |
现状与发展 | 1篇 |
预防医学 | 560篇 |
眼科学 | 1025篇 |
药学 | 973篇 |
8篇 | |
中国医学 | 272篇 |
肿瘤学 | 416篇 |
出版年
2024年 | 74篇 |
2023年 | 597篇 |
2022年 | 1062篇 |
2021年 | 1624篇 |
2020年 | 1496篇 |
2019年 | 1424篇 |
2018年 | 1302篇 |
2017年 | 971篇 |
2016年 | 895篇 |
2015年 | 946篇 |
2014年 | 1816篇 |
2013年 | 1723篇 |
2012年 | 1211篇 |
2011年 | 1428篇 |
2010年 | 1132篇 |
2009年 | 1135篇 |
2008年 | 1063篇 |
2007年 | 1091篇 |
2006年 | 1046篇 |
2005年 | 965篇 |
2004年 | 737篇 |
2003年 | 738篇 |
2002年 | 658篇 |
2001年 | 596篇 |
2000年 | 454篇 |
1999年 | 445篇 |
1998年 | 364篇 |
1997年 | 312篇 |
1996年 | 326篇 |
1995年 | 280篇 |
1994年 | 236篇 |
1993年 | 218篇 |
1992年 | 177篇 |
1991年 | 151篇 |
1990年 | 139篇 |
1989年 | 123篇 |
1988年 | 92篇 |
1987年 | 100篇 |
1986年 | 102篇 |
1985年 | 105篇 |
1984年 | 103篇 |
1983年 | 67篇 |
1982年 | 69篇 |
1981年 | 53篇 |
1980年 | 48篇 |
1979年 | 26篇 |
1978年 | 26篇 |
1977年 | 13篇 |
1976年 | 19篇 |
1973年 | 14篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
71.
目的:回顾性总结重症心脏瓣膜病置换术体外循环经验.方法:105例重症心脏瓣膜病患者,使用stockerⅢ型心肺机及膜式氧合器,体外循环中采用中度低温,预充白蛋白并附加人工肾超滤,心肌保护用高钾含血停搏液灌注.结果:105例患者均顺利脱机,无1例死亡.体外循环时间60~180 min,主动脉阻断时间60~120 min,所有患者均顺利脱离体外循环,心脏自动复跳86例,电击19例.结论:手术中加强心肌保护,可减低手术后的功能衰竭和并发症,并可有效提高手术成功率. 相似文献
72.
本文测定了对照组及两个萘普生(前列腺素合成酶抑制剂)处理组大鼠着床期宫内PGF2α的含量。结果表明,对照组、萘普生低剂量组(2mg/kg体重)和高剂量组(20mg/kg体重)的PGF2α含量分别为6.71±0.93、2.19±0.34和1.01±0.18ng/100g组织(三组间P<0.01)。同时,还观察到在本实验条件下,萘普生无明显干扰节育器抗生育作用,药物本身亦未呈现显著抗生育活性。 相似文献
73.
目的:探讨白内障手术后急性高眼压的快速处理。方法:对于手术前无青光眼史、眼压正常的白内障患者,手术后眼压增高者,应用表面麻醉,开睑,1mL消毒注射器压迫辅助切口后唇,房水自然流出,眼压随即下降。结果:共处理白内障手术后高眼压67例,放水1次眼压恢复正常者65例,两次放水眼压恢复正常者1例,4次1例。其中6例放水后前房出血,经半卧位休息及全身应用止血药后3~5d出血吸收。无其它并发症。结论:应用辅助切口放出房水治疗白内障手术后高眼压,无应用高渗脱水剂引起肾功能障碍的风险,治疗后眼压随即下降,角膜恢复透明,高眼压临床症状立即消失,减少了高眼压对手术眼视力的损害,且无特殊并发症,经济实用,可以在临床推广应用。 相似文献
74.
目的观察动脉导管未闭经皮心导管封堵术前后右心血流动力学的变化,评价其临床意义。方法对50例动脉导管未闭儿童患者,在进行介入性经皮心导管封堵术治疗前应用X线降主动脉造影测量前,术后经导管检测右心血流动力学指标变化。结果未闭动脉导管最窄处直径(5.6±1.3)mm;术前肺动脉平均压(19.1±2.3)mmHg,左向右分流量平均为(0.41±0.13)l/min,血流分流量占肺循环血流量的比例平均为(0.17±0.03);术后肺动脉平均压(14.4±1.7)mmHg,左向右分流量平均为(0.03±0.01)l/min,血流分流量占肺循环血流量的比例平均为(0.02±0.01),相应数据比较,差异有统计学意义(P<0.05)。结论动脉导管未闭经皮心导管封堵术前后血流动力学会发生改变,肺动脉平均压,左向右分流量以及分流量占肺循环血流量的比例均会不同程度下降,这种改变可以作为评价介入治疗效果的重要指标。 相似文献
75.
经研究表明颈外静脉的瓣膜、缩窄环、瓣膜窦及窦段静脉壁共同组成一个灵敏地、高强度地抗逆流装置。本文称之为瓣膜窦段并报道189段的尸体解剖和光镜观察结果;测定尸体、活体和手术中瓣膜窦段的抗逆流功能,表明颈外静脉适于用无瓣导管作脑积水等分流途径。初步探明颈外静脉怒张的原因和消除怒张的简便方法以及术前鉴定瓣膜窦段位置和功能的方法。对2例脑积水用无瓣导管作侧脑室颈外静脉分流取得初步疗效。 相似文献
76.
Objective To construct new model of experimental abdominal aortic aneurysm (AAA) and detect the AAA outer diameter and the change of induce nitric oxide synthase(iNOS) in the abdominal aor-tic aneurysm in different period,and analysis the correlation between experimental AAA and iNOS.Methods During the operation of the experiment group,the vascular prosthesis of PTFE was implanted to the rabbit abdominal aorta to form an aneurysm,while sham operation was done in the control group.The tissue of ab-dominal aortic aneurysm was harvested in 1 d,7d,14d,and 28d after operation,respectively.The tissue bo-mogenate concentration of iNOS in the abdominal aortic aneurysm were detected by enzyme linked immu-nosorbent assay (ELISA).Results In experimental group,mean concentration of the tissue bomogenate concentration of iNOS in the abdominal aortic aneurysm in 1 d,7 d,14 d,28 d were (22.129 ±2.518)μ/mL,(27.337±5.321) μ/mL,(36.047±4.584)μ/mL,(44.756±1.799)μ/mL,respectively;In control group,that was (12.499±1.807)μ/mL.The concentration of iNOS in experimental group was significantly higher than that of control group (P < 0.01).The difference during the experimental group all had statisti-cal significance (P < 0.05).Conclusion It is possible that iNOS has some biological function during the formation and progression of the abdominal aortic aneurysm. 相似文献
77.
Results of the Ross operation in a pediatric population 总被引:1,自引:0,他引:1
Mark G. Hazekamp Heynric B. Grotenhuis Paul H. Schoof Marie E.B. Rijlaarsdam Jaap Ottenkamp Robert A.E. Dion 《European journal of cardio-thoracic surgery》2005,27(6):975-979
Objective: To analyse the results of the mid-term clinical and echocardiographic follow-up of the pediatric Ross operation. Methods: Echo-Doppler follow-up of 53 consecutive pediatric Ross procedures performed between 1994 and 2003. Median age was 9.7 years at time of operation (2 weeks–17.7 years). Six patients were younger than 3 months. Median age at follow-up was 15.6 years. Aortic valve/left ventricular outflow tract (LVOT) anomalies were congenital in 49 (92%). Seventy percent had previous surgery or balloon valvuloplasty. Root replacement was used in all. Thirteen patients (25%) had LVOT enlargement. Mean cross-clamp time was 113 (69–189) minutes. Results: Early mortality occurred in 3 patients after emergency surgery following balloon failure (n=1) and extended Ross following interrupted arch/VSD repair (n=2). Late mortality was due to LV fibroelastosis in 2 patients and complicated pulmonary artery stenting in another. RVOT reoperations were required because of late homograft obstruction in 2 patients and because of pulmonary artery stenosis in another. Five patients (9.4%) were reoperated for pulmonary autograft dilatation (n=3) and for leaflet fibrosis or perforation (n=2). Autografts were repaired in two patients, while a mechanical valve was inserted in 3 cases. At 9 years the actuarial survival and event free survival were 89 and 74%, respectively. At last follow-up 90% of autograft diameters indexed to body surface area was above the 90th percentile of normal aortic root diameters. LVOT and RVOT gradients were low and autograft insufficiency was trivial to mild in 84% and mild to moderate in 16%. Autograft stenosis was not noticed. Conclusions: The pediatric Ross procedure remains an important tool but autograft dilatation also occurs in the pediatric population. The significance of this finding has yet to be determined. 相似文献
78.
79.
放射性125I粒子组织间植入或联合放化疗治疗复发直肠癌 总被引:5,自引:1,他引:4
目的探讨超声或CT引导下放射性125I粒子组织间植入治疗复发直肠癌的技术可行性、近期疗效和副反应.方法 15例直肠癌术后盆腔复发患者,女4例,男11例.硬膜外麻醉,2例经阴道超声引导,13例CT引导,行放射性125I粒子植入术.肿瘤匹配周边剂量为90~110 Gy,每颗粒子活度为0.50~0.70 mCi,植入33~70颗.术后24~48 h拍胸、盆腔X线片了解粒子是否发生移位.术后6例加三维适形放疗,4~6野/次,200~300 cGy/次,5次/周,总剂量为4 500~5 000 cGy,间隔4周.2例粒子治疗后加草酸铂、5-氟尿嘧啶和四氢叶酸化疗1个周期,随访3~15个月,根据CT扫描结果判断肿瘤大小. 结果术后平均7天疼痛缓解,其中12例完全缓解,2例部分缓解,1例无变化,有效率93%(14/15).9例肿瘤完全缓解,2例部分缓解,4例局部进展,局部控制率73%(11/15).2例术后6个月和12个月时死于肺转移.1例1颗粒子移位至盆壁,随访12个月无症状.无治疗相关并发症和副作用发生. 结论经超声或CT引导放射性125I粒子植入治疗复发直肠癌具有安全、微创、并发症发生率低和疗效肯定等优势,粒子治疗后应配合外放疗和全身化疗,有望进一步提高疗效. 相似文献
80.
Hirotaka Inaba Kazuhiko Higuchi Kenji Koseni Haruo Yamauchi Junichi Naganuma 《The Japanese Journal of Thoracic and Cardiovascular Surgery》2005,53(11):587-592
OBJECTIVE: The aortic connector system was used to minimize cerebrovascular complications when performing the proximal anastomosis of vein grafts during coronary artery bypass grafting (CABG). The goal of this study was to investigate the intermediate outcomes of patients undergoing CABG with the aortic connector system. METHODS: The aortic connector was used on nine patients undergoing CABG between November 2002 and July 2003. Intermediate outcomes of the patients were examined, and the results of coronary angiography, which were performed before patient discharge and at least 6 months after discharge, were evaluated. RESULTS: There were no operative deaths or cerebrovascular accidents. One patient died 9 months after discharge, one patient had angina, and the remaining seven patients were asymptomatic. When evaluating the results of angiography performed before patient discharge, two of the 21 distal vein graft anastomoses were occluded (patency rate, 90.5%), but there was no stenosis or occlusion at the proximal anastomoses sites that were performed using the aortic connector. When evaluating the results of the second angiography performed after patient discharge, four of the eight proximal anastomoses were patent, one was completely occluded, two had 90% stenosis and one had 75% stenosis. Further, four of the 18 distal anastomoses were occluded (patency rate, 77.8%). There was no significant difference in graft flow or device size when comparing patients with patent vein grafts and those with stenotic or occluded vein grafts. CONCLUSION: Intermediate outcomes of vein grafting using the aortic connector were suboptimal. Long-term outcome data are forthcoming. 相似文献